Genomic Market Research Reports

"...... br /> - 10X Genomics Inc. - Abcam Plc - Agilent Technologies Inc. - Becton Dickinson and Co. - BGI Genomics Co. Ltd. - Bio Rad Laboratories Inc. - Danaher Corp. - Eppendorf AG - Eurofins Scient......"

"...... the forecast years. Genomics is the field of genetics involving the sequencing and analysis of organism genomes. The genome is the entire DNA content within a unit of the organism. Genomics experts work to determine complete DNA sequenc......"

"...... Global Agrigenomics Market The global Agrigenomics market is projected to grow from US$ 5185.9 million in 2023 to US$ 7524.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period. Thermo Fisher Sci......"

"...... fins, Zoetis, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Agrigenomics from 2017-2022, and provides extensive......"

"...... rowth Rate (CAGR) of 10.8% during the forecast period. The global genomics market is chiefly driven by the intensifying level of competition in the global pharmaceutical industry and the increased use of genomics in research and develo......"

"...... The US & Canada market for Genomics In Cancer Care is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Genomics In Cancer Care......"

"...... 47 Million USD in 2022, and will reach 7676.54 Million USD in 2028, with a CAGR of 6.92% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Agrigenomics industry, and breaks down ......"

"...... ......"

"...... eratives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies. The Genomics market forecast report identifies growth o......"

"...... developments in sequencing technologies and a better understanding of genomics have increased the efficiency of biomarkers in disease detection. Since precise diagnosis and personalized medicine increase survival rates as well as reduce the financial......"